Protease-activated receptor 2, rather than protease-activated receptor 1, contributes to the aggressive properties of synovial fibroblasts in rheumatoid arthritis

Arthritis and Rheumatism

Volumn 64, Issue 1, 2012, Pages 88-98

  Xue, Meilang ^a   Chan, Yee Ka Agnes ^a   Shen, Kaitlin ^a   Dervish, Suat ^a   March, Lyn ^a   Sambrook, Philip N ^a   Jackson, Christopher J ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

GELATINASE A; GELATINASE B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 17; MITOGEN ACTIVATED PROTEIN KINASE P38; PROTEINASE ACTIVATED RECEPTOR 1; PROTEINASE ACTIVATED RECEPTOR 2; SMALL INTERFERING RNA; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ARTICLE; CELL INVASION; CELL PROLIFERATION; CYTOKINE RELEASE; ENZYME ACTIVATION; ENZYME ANALYSIS; ENZYME INHIBITION; ENZYME LINKED IMMUNOSORBENT ASSAY; FIBROBLAST; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; HUMAN TISSUE; IMMUNOFLUORESCENCE; KNOCKOUT MOUSE; MOUSE; NONHUMAN; OSTEOARTHRITIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RHEUMATOID ARTHRITIS; SYNOVIAL FIBROBLAST; WESTERN BLOTTING; ZYMOGRAPHY;

AGED; ANIMALS; ARTHRITIS, RHEUMATOID; CELL MOVEMENT; CELL PROLIFERATION; CELL SURVIVAL; FEMALE; FIBROBLASTS; FORMAZANS; HUMANS; MALE; MATRIX METALLOPROTEINASE 9; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; OSTEOARTHRITIS; OSTEOARTHRITIS, KNEE; RECEPTOR, PAR-1; RECEPTOR, PAR-2; RNA INTERFERENCE; RNA, SMALL INTERFERING; SYNOVIAL MEMBRANE; TETRAZOLIUM SALTS; TRANSFECTION; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84855283952     PISSN: 00043591     EISSN: 15290131     Source Type: Journal    
DOI: 10.1002/art.33323     Document Type: Article

References (50)

1. Ossovskaya VS, Bunnett NW,. Protease-activated receptors: contribution to physiology and disease. Physiol Rev 2004; 84: 579-621. (Pubitemid 38365493)
2. Riewald M, Petrovan RJ, Donner A, Mueller BM, Ruf W,. Activation of endothelial cell protease activated receptor 1 by the protein C pathway. Science 2002; 296: 1880-2. (Pubitemid 34596276)
3. Shpacovitch V, Feld M, Hollenberg MD, Luger TA, Steinhoff M,. Role of protease-activated receptors in inflammatory responses, innate and adaptive immunity. J Leukoc Biol 2008; 83: 1309-22. (Pubitemid 351960309)
4. Pap T, Meinecke I, Muller-Ladner U, Gay S,. Are fibroblasts involved in joint destruction? Ann Rheum Dis 2005; 64 SUPPL. IV: iv52-4. (Pubitemid 41532019)
5. Firestein GS,. Invasive fibroblast-like synoviocytes in rheumatoid arthritis: passive responders or transformed aggressors? [review]. Arthritis Rheum 1996; 39: 1781-90. (Pubitemid 26378569)
6. Tarkowski A, Jonsson R, Holmdahl R, Klareskog L,. Immunohistochemical characterization of synovial cells in arthritic MRL-lpr/lpr mice. Arthritis Rheum 1987; 30: 75-82. (Pubitemid 17007263)
7. Muller-Ladner U, Kriegsmann J, Franklin BN, Matsumoto S, Geiler T, Gay RE, et al. Synovial fibroblasts of patients with rheumatoid arthritis attach to and invade normal human cartilage when engrafted into SCID mice. Am J Pathol 1996; 149: 1607-15. (Pubitemid 26363967)
8. Lefevre S, Knedla A, Tennie C, Kampmann A, Wunrau C, Dinser R, et al. Synovial fibroblasts spread rheumatoid arthritis to unaffected joints. Nat Med 2009; 15: 1414-20.
9. Ferrell WR, Lockhart JC, Kelso EB, Dunning L, Plevin R, Meek SE, et al. Essential role for proteinase-activated receptor-2 in arthritis. J Clin Invest 2003; 111: 35-41. (Pubitemid 36134846)
10. Kelso EB, Ferrell WR, Lockhart JC, Elias-Jones I, Hembrough T, Dunning L, et al. Expression and proinflammatory role of proteinase-activated receptor 2 in rheumatoid synovium: ex vivo studies using a novel proteinase-activated receptor 2 antagonist. Arthritis Rheum 2007; 56: 765-71. (Pubitemid 46399423)
11. Busso N, Frasnelli M, Feifel R, Cenni B, Steinhoff M, Hamilton J, et al. Evaluation of protease-activated receptor 2 in murine models of arthritis. Arthritis Rheum 2007; 56: 101-7. (Pubitemid 46106182)
12. Marty I, Peclat V, Kirdaite G, Salvi R, So A, Busso N,. Amelioration of collagen-induced arthritis by thrombin inhibition. J Clin Invest 2001; 107: 631-40. (Pubitemid 32205184)
13. Morris R, Winyard PG, Brass LF, Blake DR, Morris CJ,. Thrombin receptor expression in rheumatoid and osteoarthritic synovial tissue. Ann Rheum Dis 1996; 55: 841-3. (Pubitemid 26392286)
14. Yang YH, Hall P, Little CB, Fosang AJ, Milenkovski G, Santos L, et al. Reduction of arthritis severity in protease-activated receptor-deficient mice. Arthritis Rheum 2005; 52: 1325-32. (Pubitemid 40530144)
15. Neumann E, Lefevre S, Zimmermann B, Gay S, Muller-Ladner U,. Rheumatoid arthritis progression mediated by activated synovial fibroblasts. Trends Mol Med 2010; 16: 458-68.
16. Kamath L, Meydani A, Foss F, Kuliopulos A,. Signaling from protease-activated receptor-1 inhibits migration and invasion of breast cancer cells. Cancer Res 2001; 61: 5933-40. (Pubitemid 32769114)
17. Morris DR, Ding Y, Ricks TK, Gullapalli A, Wolfe BL, Trejo J,. Protease-activated receptor-2 is essential for factor VIIa and Xa-induced signaling, migration, and invasion of breast cancer cells. Cancer Res 2006; 66: 307-14. (Pubitemid 43166037)
18. Versteeg HH, Schaffner F, Kerver M, Ellies LG, Andrade-Gordon P, Mueller BM, et al. Protease-activated receptor (PAR) 2, but not PAR-1, signaling promotes the development of mammary adenocarcinoma in polyoma middle T mice. Cancer Res 2008; 68: 7219-27.
19. Nierodzik ML, Chen K, Takeshita K, Li JJ, Huang YQ, Feng XS, et al. Protease-activated receptor 1 (PAR-1) is required and rate-limiting for thrombin-enhanced experimental pulmonary metastasis. Blood 1998; 92: 3694-700. (Pubitemid 28525196)
20. Villares GJ, Zigler M, Dobroff AS, Wang H, Song R, Melnikova VO, et al. Protease activated receptor-1 inhibits the Maspin tumor-suppressor gene to determine the melanoma metastatic phenotype. Proc Natl Acad Sci U S A 2011; 108: 626-31.
21. Silini A, Ghilardi C, Ardinghi C, Bernasconi S, Oliva P, Carraro F, et al. Protease-activated receptor-1 (PAR-1) promotes the motility of human melanomas and is associated to their metastatic phenotype. Clin Exp Metastasis 2010; 27: 43-53.
22. Hirano F, Kobayashi A, Hirano Y, Nomura Y, Fukawa E, Makino I,. Thrombin-induced expression of RANTES mRNA through protease activated receptor-1 in human synovial fibroblasts. Ann Rheum Dis 2002; 61: 834-7.
23. Abe K, Aslam A, Walls AF, Sato T, Inoue H,. Up-regulation of protease-activated receptor-2 by bFGF in cultured human synovial fibroblasts. Life Sci 2006; 79: 898-904.
24. Altman R, Asch E, Bloch D, Bole G, Borenstein D, Brandt K, et al. Development of criteria for the classification and reporting of osteoarthritis: classification of osteoarthritis of the knee. Arthritis Rheum 1986; 29: 1039-49.
25. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988; 31: 315-24. (Pubitemid 18091653)
26. Xue M, March L, Sambrook PN, Jackson CJ,. Differential regulation of matrix metalloproteinase 2 and matrix metalloproteinase 9 by activated protein C: relevance to inflammation in rheumatoid arthritis. Arthritis Rheum 2007; 56: 2864-74. (Pubitemid 47502732)
27. Le NT, Xue M, Castelnoble LA, Jackson CJ,. The dual personalities of matrix metalloproteinases in inflammation. Front Biosci 2007; 12: 1475-87. (Pubitemid 46846846)
28. McCoy KL, Traynelis SF, Hepler JR,. PAR-1 and PAR-2 couple to overlapping and distinct sets of G proteins and linked signaling pathways to differentially regulate cell physiology. Mol Pharmacol 2010; 77: 1005-15.
29. Shishodia S, Aggarwal BB,. Nuclear factor-κB activation mediates cellular transformation, proliferation, invasion angiogenesis and metastasis of cancer. Cancer Treat Res 2004; 119: 139-73.
30. Buisson-Legendre N, Smith S, March L, Jackson C,. Elevation of activated protein C in synovial joints in rheumatoid arthritis and its correlation with matrix metalloproteinase 2. Arthritis Rheum 2004; 50: 2151-6. (Pubitemid 38924392)
31. Itoh T, Matsuda H, Tanioka M, Kuwabara K, Itohara S, Suzuki R,. The role of matrix metalloproteinase-2 and matrix metalloproteinase-9 in antibody-induced arthritis. J Immunol 2002; 169: 2643-7. (Pubitemid 34921011)
32. Konttinen YT, Ainola M, Valleala H, Ma J, Ida H, Mandelin J, et al. Analysis of 16 different matrix metalloproteinases (MMP-1 to MMP-20) in the synovial membrane: different profiles in trauma and rheumatoid arthritis. Ann Rheum Dis 1999; 58: 691-7. (Pubitemid 29517255)
33. Fabrizi C, Pompili E, Panetta B, Nori SL, Fumagalli L,. Protease-activated receptor-1 regulates cytokine production and induces the suppressor of cytokine signaling-3 in microglia. Int J Mol Med 2009; 24: 367-71.
34. Tanaka Y, Sekiguchi F, Hong H, Kawabata A,. PAR-2 triggers IL-8 release via MEK/ERK and PI3-kinase/Akt pathways in GI epithelial cells. Biochem Biophys Res Commun 2008; 377: 622-6.
35. Johansson U, Lawson C, Dabare M, Syndercombe-Court, Newland AC, Howells GL, et al. Human peripheral blood monocytes express protease receptor-2 and respond to receptor activation by production of IL-6, IL-8, and IL-1β. J Leukoc Biol 2005; 78: 967-75. (Pubitemid 41384413)
36. Chiu YC, Fong YC, Lai CH, Hung CH, Hsu HC, Lee TS, et al. Thrombin-induced IL-6 production in human synovial fibroblasts is mediated by PAR-1, phospholipase C, protein kinase Cα, c-Src, NF-κB and p300 pathway. Mol Immunol 2008; 45: 1587-99.
37. Neumann E, Riepl B, Knedla A, Lefevre S, Tarner IH, Grifka J, et al. Cell culture and passaging alters gene expression pattern and proliferation rate in rheumatoid arthritis synovial fibroblasts. Arthritis Res Ther 2010; 12: R83.
38. Martin L, Auge C, Boue J, Buresi MC, Chapman K, Asfaha S, et al. Thrombin receptor: an endogenous inhibitor of inflammatory pain, activating opioid pathways. Pain 2009; 146: 121-9.
39. Traynelis SF, Trejo J,. Protease-activated receptor signaling: new roles and regulatory mechanisms. Curr Opin Hematol 2007; 14: 230-5. (Pubitemid 46597608)
40. q and GβIγ regulate PAR-1 signaling of thrombin-induced NF-κB activation and ICAM-1 transcription in endothelial cells. Circ Res 2002; 91: 398-405. (Pubitemid 35034207)
41. Gortz B, Hayer S, Tuerck B, Zwerina J, Smolen JS, Schett G,. Tumour necrosis factor activates the mitogen-activated protein kinases p38α and ERK in the synovial membrane in vivo. Arthritis Res Ther 2005; 7: R1140-7.
42. Rohani MG, DiJulio DH, An JY, Hacker BM, Dale BA, Chung WO,. PAR-1- and PAR-2-induced innate immune markers are negatively regulated by PI3K/Akt signaling pathway in oral keratinocytes. BMC Immunol 2010; 11: 53.
43. Simmonds RE, Foxwell BM,. Signalling, inflammation and arthritis: NF-κB and its relevance to arthritis and inflammation. Rheumatology (Oxford) 2008; 47: 584-90. (Pubitemid 351619194)
44. Yamasaki S, Kawakami A, Nakashima T, Nakamura H, Kamachi M, Honda S, et al. Importance of NF-κB in rheumatoid synovial tissues: in situ NF-κB expression and in vitro study using cultured synovial cells. Ann Rheum Dis 2001; 60: 678-84. (Pubitemid 32588371)
45. 2 production by suppressing cyclooxygenase-2 upregulation and Akt-dependent activation of nuclear factor-κB in human lung epithelial cells. J Pharmacol Sci 2010; 114: 225-9.
46. Buddenkotte J, Stroh C, Engels IH, Moormann C, Shpacovitch VM, Seeliger S, et al. Agonists of proteinase-activated receptor-2 stimulate upregulation of intercellular cell adhesion molecule-1 in primary human keratinocytes via activation of NF-κB. J Invest Dermatol 2005; 124: 38-45. (Pubitemid 40100946)
47. Vliagoftis H, Schwingshackl A, Milne CD, Duszyk M, Hollenberg MD, Wallace JL, et al. Proteinase-activated receptor-2-mediated matrix metalloproteinase-9 release from airway epithelial cells. J Allergy Clin Immunol 2000; 106: 537-45. (Pubitemid 32037707)
48. Bretschneider E, Kaufmann R, Braun M, Wittpoth M, Glusa E, Nowak G, et al. Evidence for proteinase-activated receptor-2 (PAR-2)-mediated mitogenesis in coronary artery smooth muscle cells. Br J Pharmacol 1999; 126: 1735-40. (Pubitemid 29213090)
49. Youssef S, Steinman L,. At once harmful and beneficial: the dual properties of NF-κB. Nat Immunol 2006; 7: 901-2. (Pubitemid 44263900)
50. Ulivi V, Giannoni P, Gentili C, Cancedda R, Descalzi F,. p38/NF-κB-dependent expression of COX-2 during differentiation and inflammatory response of chondrocytes. J Cell Biochem 2008; 104: 1393-406. (Pubitemid 351961709)